Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terence W Friedlander

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Clinical Advances in Hematology & Oncology : H&O|September 20, 2022
When to use somatic tumor testing in prostate cancerTerence W Friedlander
European Urology|August 18, 2015
A Stepping Stone Toward Personalized Oncology: Genomic Analysis of Circulating Tumor Cells to Guide Management of Metastatic Castration-resistant Prostate CancerArchana Anantharaman, Terence W Friedlander
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2014
The end of the beginning: circulating tumor cells as a biomarker in castration-resistant prostate cancerTerence W Friedlander, Lawrence Fong
Oncology (Williston Park, N.Y.)|January 17, 2015
The double-edged sword of ADT: emerging evidence of cardiovascular, pulmonary, and renal risksArchana Anantharaman, Terence W Friedlander
Urologic Oncology|December 27, 2015
Targeting the androgen receptor in metastatic castrate-resistant prostate cancer: A reviewArchana Anantharaman, Terence W Friedlander
The Journal of Urology|October 2, 2010
Editorial commentTerence W Friedlander, Charles J Ryan
Current Oncology Reports|April 2, 2009
Novel hormonal approaches in prostate cancerTerence W Friedlander, Charles J Ryan
The Urologic Clinics of North America|October 23, 2012
Targeting the androgen receptorTerence W Friedlander, Charles J Ryan
European Urology|September 22, 2020
Does One Size Fit All? Re-evaluating Prostate-specific Antigen Progression Thresholds for Clinical TrialsDaniel H Kwon, Terence W Friedlander
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Personalizing Therapy for Metastatic Prostate Cancer: The Role of Solid and Liquid Tumor BiopsiesTerence W Friedlander, Colin C Pritchard, Himisha Beltran
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Clinical Advances in Hematology & Oncology : H&O|September 20, 2022
When to use somatic tumor testing in prostate cancerTerence W Friedlander
European Urology|August 18, 2015
A Stepping Stone Toward Personalized Oncology: Genomic Analysis of Circulating Tumor Cells to Guide Management of Metastatic Castration-resistant Prostate CancerArchana Anantharaman, Terence W Friedlander
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2014
The end of the beginning: circulating tumor cells as a biomarker in castration-resistant prostate cancerTerence W Friedlander, Lawrence Fong
Oncology (Williston Park, N.Y.)|January 17, 2015
The double-edged sword of ADT: emerging evidence of cardiovascular, pulmonary, and renal risksArchana Anantharaman, Terence W Friedlander
Urologic Oncology|December 27, 2015
Targeting the androgen receptor in metastatic castrate-resistant prostate cancer: A reviewArchana Anantharaman, Terence W Friedlander
The Journal of Urology|October 2, 2010
Editorial commentTerence W Friedlander, Charles J Ryan
Current Oncology Reports|April 2, 2009
Novel hormonal approaches in prostate cancerTerence W Friedlander, Charles J Ryan
The Urologic Clinics of North America|October 23, 2012
Targeting the androgen receptorTerence W Friedlander, Charles J Ryan
European Urology|September 22, 2020
Does One Size Fit All? Re-evaluating Prostate-specific Antigen Progression Thresholds for Clinical TrialsDaniel H Kwon, Terence W Friedlander
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Personalizing Therapy for Metastatic Prostate Cancer: The Role of Solid and Liquid Tumor BiopsiesTerence W Friedlander, Colin C Pritchard, Himisha Beltran
Pageof 5